[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.142.229. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
August 27, 2003

Stroke Prevention in Atrial Fibrillation

Author Affiliations

Author Affiliation: Case Western Reserve University, University Hospitals of Cleveland, Cleveland, Ohio.

JAMA. 2003;290(8):1093-1095. doi:10.1001/jama.290.8.1093

Atrial fibrillation is a relatively common clinical problem, affecting an estimated 2.3 million adults in the United States.1 The prevalence of atrial fibrillation increases with age; nearly 4% of persons aged 60 years or older and 9% of those aged 80 years or older have atrial fibrillation,1 and about half the patients in the United States with atrial fibrillation are older than 75 years.2 By the year 2050, the prevalence of atrial fibrillation is expected to increase about 2.5 fold, with most of that increase explained by the growing proportion of individuals living into their 80s and beyond.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×